Alzheimers Drugs Market: 2019 Industry Analysis, Size, Trends, Growth and Forecast 2030 - H. Lundbeck A/S, Eisai Co, Avanir Pharmaceuticals
Alzheimer’s drugs are the medications that reduce the symptoms of the disease or in few cases also control the behavioral symptoms. At present, no medication is prescribed for the said disease. Till date, the FDA has approved two medications for patients suffering from Alzheimer’s disease including memantine and cholinesterase inhibitors. Memantine helps to treat the cognitive symptoms that comprise confusion, memory loss, reasoning, thinking issues, and more, whereas cholinesterase inhibitors are the chemicals that prevent the breaking of butyrylcholine and...
View full press release